Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin [Phase 1]
Phase 1 trial update of Gemcitabine in combination with TheraSphere Y-90 for hepatic tumors of pancreatobiliary origin. The study status is …
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: (PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer [Phase 1]
Phase 1 trial update on IMPRIME PGG with BTH1704 plus gemcitabine for advanced pancreatic cancer; the study NCT02132403 has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 trial of immunotoxin therapy in patients with advanced cancers has completed, with results spanning several gynecologic and non-gy…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of an immunotoxin therapy in patients with advanced solid tumors has completed, spanning eight cancer types including cervical…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update on LMB-9 immunotoxin in patients with advanced solid tumors. The study has completed and includes bladder cancer, breas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-04-28Clinical Trial Update: Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating gemcitabine hydrochloride with or without bevacizumab in patients undergoing surgery for pancreatic cancer has be…
-
CLINICAL_TRIALS withdrawal · 2015-04-28Clinical Trial Update: Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation [Phase 1]
A Phase 1 trial of tolfenamic acid with gemcitabine and radiation for locally advanced or metastatic pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update examining the combination of calcitriol and docetaxel in patients with metastatic or locally advanced pancreat…
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
This Phase 2 trial evaluated adding metformin hydrochloride to chemotherapy for metastatic pancreatic cancer. The study was terminated.
-
CLINICAL_TRIALS research · 2015-04-23Clinical Trial Update: Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic Ladder [NA]
A clinical trial investigating invasive treatment for pain associated with pancreatic cancer across different levels of the WHO analgesic la…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel and bryostatin-1 in advanced pancreatic cancer completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) [Phase 2]
A Phase 2 trial (PESUP) evaluating pancreatic enzyme supplementation in unresectable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer [Phase 2]
Phase 2 trial evaluating GI-4000 in combination with gemcitabine versus placebo for non-metastatic, post-resection pancreatic cancer has com…
-
CLINICAL_TRIALS withdrawal · 2015-04-06Clinical Trial Update: Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery [NA]
The clinical trial investigating secretin-enhanced MRCP and pancreatic function after pancreatic cancer surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-03Clinical Trial Update: Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas [Phase 2]
A Phase 2 trial of Cvac as maintenance therapy for patients with resected Stage I or Stage II pancreatic adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma [Phase 1, Phase 2]
Phase I/II open-label dose-escalation study of PHY906 plus capecitabine in advanced pancreatic cancer evaluated safety and preliminary effic…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer [Phase 3]
A Phase 3 trial of neoadjuvant gemcitabine/oxaliplatin followed by adjuvant gemcitabine in resectable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle [NA]
Clinical trial comparing EUS-FNA to EUS-FNB with a novel core biopsy needle in pancreatic cancer and related conditions; completed with resu…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating dasatinib in combination with gemcitabine for locally advanced pancreatic cancer has completed, with results posted…
-
CLINICAL_TRIALS withdrawal · 2015-03-17Clinical Trial Update: A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . . [Phase 2]
A Phase 2 pilot study evaluating neoadjuvant chemoradiotherapy with capecitabine for pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-13Clinical Trial Update: Strength Training on Pancreatic Cancer [NA]
The clinical trial NCT01395563 evaluating strength training for pancreatic cancer and related conditions has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 trial evaluated simtuzumab in combination with gemcitabine for metastatic pancreatic cancer, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy [Phase 3]
Phase 3 trial comparing acute normovolemic hemodilution versus standard intraoperative management in patients undergoing hepatic resection a…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
Clinical trial update for INST 0603C in unresectable/metastatic pancreatic cancer; study terminated with results posted in 2015.
-
CLINICAL_TRIALS research · 2015-02-18Clinical Trial Update: The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib [Phase 2]
Phase 2 trial assessing whether EGFR mutation status influences outcomes in metastatic pancreatic cancer patients treated with gemcitabine, …